News | August 06, 2025
Gland Pharma Q1 FY26 YoY PAT up by 50% to Rs. 216 Cr
Cenexi reports an EBITDA breakeven for the quarter
Cenexi reports an EBITDA breakeven for the quarter
The operating profit (EBITDA) rose 20.7% to Rs. 156.4 crore
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
Bliss GVS Pharma has reported total income of Rs. 242.92 crores during the period ended June 30, 2025
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
Novartis India has reported total income of Rs. 98.16 crores during the period ended June 30, 2025
Torrent Pharmaceuticals has reported total income of Rs. 3,141 crores during the period ended June 30, 2025
Subscribe To Our Newsletter & Stay Updated
